HUP0002186A3 - Compounds useful for inhibition of farnesyl protein transferase - Google Patents

Compounds useful for inhibition of farnesyl protein transferase

Info

Publication number
HUP0002186A3
HUP0002186A3 HU0002186A HUP0002186A HUP0002186A3 HU P0002186 A3 HUP0002186 A3 HU P0002186A3 HU 0002186 A HU0002186 A HU 0002186A HU P0002186 A HUP0002186 A HU P0002186A HU P0002186 A3 HUP0002186 A3 HU P0002186A3
Authority
HU
Hungary
Prior art keywords
inhibition
compounds useful
protein transferase
farnesyl protein
farnesyl
Prior art date
Application number
HU0002186A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HUP0002186A2 publication Critical patent/HUP0002186A2/hu
Publication of HUP0002186A3 publication Critical patent/HUP0002186A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/08Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Materials For Medical Uses (AREA)
HU0002186A 1997-06-17 1998-06-15 Compounds useful for inhibition of farnesyl protein transferase HUP0002186A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87773997A 1997-06-17 1997-06-17
PCT/US1998/011494 WO1998057955A1 (en) 1997-06-17 1998-06-15 Compounds useful for inhibition of farnesyl protein transferase

Publications (2)

Publication Number Publication Date
HUP0002186A2 HUP0002186A2 (hu) 2001-04-28
HUP0002186A3 true HUP0002186A3 (en) 2002-04-29

Family

ID=25370613

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002186A HUP0002186A3 (en) 1997-06-17 1998-06-15 Compounds useful for inhibition of farnesyl protein transferase

Country Status (14)

Country Link
EP (1) EP0993459B1 (hu)
JP (1) JP2002504143A (hu)
KR (1) KR20010013953A (hu)
CN (1) CN1286690A (hu)
AT (1) ATE227281T1 (hu)
AU (1) AU7815198A (hu)
CA (1) CA2294351C (hu)
DE (1) DE69809238T2 (hu)
ES (1) ES2182324T3 (hu)
HK (1) HK1024686A1 (hu)
HU (1) HUP0002186A3 (hu)
IL (1) IL133447A0 (hu)
NZ (1) NZ501617A (hu)
WO (1) WO1998057955A1 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110483384B (zh) * 2018-05-14 2021-05-14 新发药业有限公司 一种3,5-二卤代-4-吡啶酮-1-乙酸的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826853A (en) * 1986-10-31 1989-05-02 Schering Corporation 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
WO1995010515A1 (en) * 1993-10-15 1995-04-20 Schering Corporation Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
IL128931A0 (en) * 1996-09-13 2000-02-17 Schering Corp Tricylic antitumor compounds being farnesyl protein transferase inhibitors

Also Published As

Publication number Publication date
HK1024686A1 (en) 2000-10-20
AU7815198A (en) 1999-01-04
ATE227281T1 (de) 2002-11-15
HUP0002186A2 (hu) 2001-04-28
IL133447A0 (en) 2001-04-30
DE69809238D1 (de) 2002-12-12
CA2294351C (en) 2008-09-02
JP2002504143A (ja) 2002-02-05
WO1998057955A1 (en) 1998-12-23
CN1286690A (zh) 2001-03-07
KR20010013953A (ko) 2001-02-26
CA2294351A1 (en) 1998-12-23
ES2182324T3 (es) 2003-03-01
NZ501617A (en) 2001-09-28
EP0993459A1 (en) 2000-04-19
DE69809238T2 (de) 2003-09-18
EP0993459B1 (en) 2002-11-06

Similar Documents

Publication Publication Date Title
HUP0004148A3 (en) Inhibitors of farnesyl protein transferase
IL124197A (en) Inhibitors of farnesyl protein transferase
IL126833A0 (en) Inhibitors of protein farnesyl transferase
EP0918771A4 (en) THIADIOXOBENZODIAZEPINES FOR USE AS FARNESYL PROTEIN TRANSFERASE INHIBITORS
EP0696593A3 (en) Farnesyl protein transferase inhibitors
AU5772698A (en) Inhibitors of farnesyl protein transferase
HU9500934D0 (en) Imidazole-containing inhibitors of farnesyl protein transferase
IL123155A0 (en) 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors
EP1027042A4 (en) FARNESYL PROTEIN TRANSFERASE INHIBITORS
AP2001002058A0 (en) Farnesyl protein transferase inhibitors for treating arthropathies
GB9809869D0 (en) Inhibition of protein kinases
PL348294A1 (en) Farnesyl protein transferase inhibitors
ZA985203B (en) Compounds useful for inhibition of farnesyl protein transferase
AU5164898A (en) Thioproline-containing inhibitors of farnesyl protein transferase
ZA986623B (en) Hydantoin derivatives having an inhibitor activity for farnesyl transferase
ZA985211B (en) Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors
HUP0202152A2 (en) Tricyclyc farnesyl protein transferase inhibitors
ZA985210B (en) Compounds for the inhibition of farnesyl protein transferase
HUP0002186A3 (en) Compounds useful for inhibition of farnesyl protein transferase
ZA985214B (en) Compounds useful for inhibition of farnesyl protein transferase
IL130453A0 (en) Farnesyl transferase inhibitors
HUP9903221A3 (en) Inhibitors of protein farnesyl transferase
ZA971621B (en) Inhibitors of farnesyl protein transferase
IL149870A0 (en) Inhibitors of farnesyl protein transferase
GB9609981D0 (en) Inhibitors of farnesyl-protien transferase